Other risk factors for pancreatic cancer: Hormonal aspects

Annals of Oncology

Volumn 10, Issue SUPPL. 4, 1999, Pages

  Andren Sandberg A ^a   Hoem, D ^a   Bäckman, Pia Lena ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cholecystokinin; Estrogen; Hormones; Pancreatic cancer; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; COMPLEMENTARY DNA; ESTROGEN; ESTROGEN RECEPTOR; PLACEBO; SEX HORMONE; TAMOXIFEN; TESTOSTERONE;

ADVANCED CANCER; ANIMAL CELL; ANIMAL TISSUE; CANCER CELL CULTURE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FAT INTAKE; FEMALE; HAMSTER; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; OVARIECTOMY; PANCREAS CANCER; PRECANCER; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; TRANSGENIC MOUSE;

EID: 0032783926     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/10.suppl_4.S131     Document Type: Conference Paper

References (61)

1. Rosenberg L, Barkun AN, Denis MH et al. Low dose octreotide and tamoxifen in the treatment of adenocarcinoma of the pancreas. Cancer 1995; 75: 23-8.
2. Lipton A, Harvey HA, Santen RJ et al. FAM chemotherapy +/-aminoglutethimide in the treatment of pancreatic carcinoma. Eur J Surg Oncol 1990; 16: 12-4.
3. Å. Andrén-Sandberg. Demographics of exocrine pancreatic cancer with special reference to age, sex, and time trends. Int J Pancreatol 1993; 16: 214-6.
4. Bäckman PL, Barlow L, Å. Andrén-Sandberg. Decreasing incidence of exocrine pancreatic cancer in Sweden. Int J Pancreatol 1995; 18: 289-90.
5. Lin RS, Kessler JI. A multifactorial model for pancreatic cancer. JAMA 1981; 245: 147-52.
6. Stace NE, Palmer TJ, Vaja S et al. Longterm pancreaticobiliary diversion stimulates hyperplastic and adenomateous nodules in the rat pancreas: a new model for spontaneous tumor formation. Gut 1987; 28(S1): 265-8.
7. Smith JP, Fantaskey AP, Liu GZ et al. Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 1995; 268: R135-41.
8. Borch K, Kullman E, Ledin T, Ihse I. Increased incidence of pancreatic neoplasia in pernicious anemia. World J Surg 1988; 12: 866-70.
9. Å. Andrén-Sandberg Estrogens and pancreatic cancer. Some recent aspects. Scand J Gastroenterol 1986; 21: 129-33.
10. Å. Andrén-Sandberg. Progress in estrogen receptors and estrogen-binding proteins in pancreatic cancer. Organ System Newsletter 1986; 2 (3): 12-3.
11. Greenway BA. Carcinoma of the exocrine pancreas: a sex hormone responsive tumour? Br J Surg 1987; 74: 441-2.
12. Ullberg S, Bengtsson G. Autoradiographic studies with natural oestrogens. Acta Endocrinol 1963; 43: 75-86.
13. Mendoza-Hernández G, López-Solache I, Rendón JL et al. 17-beta-Hydroxysteroid dehydrogenase activity in canine pancreas. Biochem Biophys Res Commun 1988; 152: 376-82.
14. Sandberg AA, Rosenthal HE. Steroid receptors in exocrine glands: the pancreas and prostate. J Steroid Biochem 1979; 11: 293-9.
15. Sandberg AA, Rosenthal HE. Estrogen receptors in the pancreas. J Steroid Biochem 1974; 5: 969-75.
16. Fernstad R, Pousette Å, Carlström K. Metabolism of estrone sulphate by normal human pancreatic tissue in vitro. Scand J Gastroenterol 1987; 22: 644-8.
17. Boctor AM, Band P, Grossman A. Analysis of binding of (3H)estradiol to the cytosol fraction of rat pancreas: comparison with sites in the cytosol of uterus. Endocrinology 1983; 113: 453-62.
18. Boctor AM, Band P, Grossman A. Requirement for an accessory factor for binding of (3H)estradiol to protein in the cytosol fraction of rat pancreas. Proc Natl Acad Sci USA 1981; 78: 5648-51.
19. Band R, Richardson SB, Boctor AM et al. Somatostatin enhance binding of (3H)estradiol to a cytosolic protein in rat pancreas. Possible role of oligopeptide coligands in secretions. J Biol Chem 1983; 258: 7284-7.
20. Grossman A, Boctor AM, Band P et al. Role of steroids in secreting-modulating effect of triamcinolon and estradiol on protein synthesis and secretion from the rat exocrine pancreas. J Steroid Biocchem 1983; 19: 1069-81.
21. Tiscornia OM, Cresta MA, de Lehman ES et al. Estrogen effects on exocrine pancreatic secretion in menopausal women: A hypothesis for menopause-induced chronic pancreatitis. Mount Sinai J Med 1986; 53: 356-60.
22. Tiscornia OM, Cresta MA, de Lehman ES et al. Effects of sex and age on pancreatic secretion. Int J Pancreatol 1986; 1: 95-118.
23. Lhoste EF, Roebuch BD, Stern JE et al. Effect of orchidectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat. Pancreas 1987; 2: 38-43.
24. Gou YS, Singh P. Effects of estradiol on pancreatic amylase and cholecystokinin binding in ovariectomized guinea pigs. J Steroid Biochem 1989; 33: 459-64.
25. Beaudoin AR, Grodin G, St-Jean P et al. Steroids and the secretory function of the exocrine pancreas. Endocrinology 1986; 119: 1195-2106.
26. Morisset J, Jolicoeur L. Effect of hydrocortison on pancreatic growth in rats. Am J Physiol 1980; 239: G95-98.
27. Werlin SL, Stefanick J. Effects of hydrocortison and cholecystokininoctapeptide on neonatal rat pancreas. J Ped Gastroenterol 1982; 1: 591-5.
28. Leung YK, Jirapinyo P, Lebenthal E et al. Effect of hydrocortisone on the maturation of cholecystokinin (CCK) binding and CCK stimulated amylase release in pancreatic acini of neonatal rats. Pancreas 1987; 2: 73-8.
29. Rall L, Pictel R, Githens S et al. Glucocorticoids modulate the in vitro development of the embryonic rat pancreas. J Cell Biol 1977; 75: 398-409.
30. Saydjari R, Singh P, Affini B et al. The isolation and characterization of estrogen binding proteins in the pancreas of male and female hamsters. J Steroid Biochem 1988; 29: 41-5.
31. Parker MG. Structure and functions of estrogen receptors. Vitamin Hormon Advanc Research Applic 1996; 51: 267-87.
32. Rochefort H, Capony F, Augereau P et al. The estrogen-reguated 52K-cathepsin- D in reast cancer: from biology to clinical applications. Int J Rad Appl Instrum (B) 1987; 14: 377-84.
33. Lemoine NR, Hall PA. Models of pancreatic cancer. In: Lemoine NR, Wright NA (eds) The molecular pathology of cancer. New York: Cold Spring Harbor Laboratory Press, 1993: 135-55.
34. Sap J, Munoz A, Damm K et al. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 1986; 324: 635-40.
35. 3H-estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues. Cancer Res 1984; 44: 1575-9.
36. Markaverich BM, Roberts RR, Alejandro MA et al. The effect of low dose continuous exposure to estradiol on the estrogen receptor (type I) and nuclear type II sites. Endocrinology 1984; 114:814-20.
37. Grossman A, Boctor AM, Lane B. Dependence of pancreatic integrity on adrenal and ovarian secretions. Endocrinology 1969; 85: 956-9.
38. Fernández-del Castillo C, Díaz-Sánchez V et al. Testosterone biotransformation by the isolated perfused canine pancreas. Pancreas 1991; 6: 104-11.
39. Singh P, Owlia A, Townsend CM et al. Estradiol and progesterone receptors in the stomach and pancreas of dogs. Can J Physiol Pharmacol 1986; 64: 469-73
40. Rosenthal HE, Sandberg AA. Estrogen binding proteins in rat pancreas. J Steroid Biochem 1978; 9: 1133-9.
41. Sing P, Townsend CM, Thompson JC. Presence of estradiol binding proteins in gastrointestinal tissues of male rats. Endocrinol 1986; 119: 1648-53.
42. Pouselte Å, Carlström K, Sköldefors H et al. Purification and partial characterization of a 17-beta-estradiol-binding macromolecule in the human pancreas. Cancer Res 1982; 42: 633-7.
43. Pouselte Å, Fernstad R, Theve NO et al. Further characterization of the estrogen binding macromolecule in human pancreas. J Steroid Biochem 1985; 23: 115-9
44. Logsdon CD, Williams JA. Panceatic acini in short-term culture regulation by EGF, carbachol, insulin, and corticosterone. Am J Physiol 1983; 244: G675-82.
45. Logsdon CD, Mössner J, Williams JA et al. Glucocorticoids increase amylase mRNA levels, secretory organelles, and secretion in pancreatic AR42J cells. J Cell Biology 1985; 100: 1200-8.
46. Gullo L, Priori P, Labo G. Influence of adrenal cortex on exocrine pancreatic function. Gastroenterology 1982; 83: 92-6.
47. Singh P, Guo YS, DeBouno JF et al. Effect of estradiol on amylase release from pancreatic acini of ovariectomized guniea pigs. Endocrinology 1987; 120: 192-4.
48. Lacaine F, Houry S, Clough K et al. Is pancreatic tumor growth inhibited by sex steroid hormones? An experimental study in hamster. Dig Dis Sci 1986; 31: S68-70.
49. Sumi C, Longnecker DS, Roebuck BD et al. Inhibitory effects of estrogen and castration on the early stage of pancreatic carcinogenesis in Fischer rats treated with azaserine. Cancer Res 1989; 49: 2332-6.
50. Iqbal MJ, Greenway BA, Wilkinson ML et al. Sex-steroid enzymes aromatase and 5-alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue. Clin Sci 1983; 65: 71-5.
51. Benz C, Hollander C, Miller B. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines. Cancer Res 1986; 46: 2276-81.
52. Benz C, Lehmn C, Lee S. Steroid sensitivity and modulation of 5-fluorouracil toxicity in a human pancreatic carcinoma (abstract). 8th Annual Meeting of the European Society for Medical Oncology, Nice, December 10-13, 1982. Berlin: Springer-Verlag 1983: 3.
53. 14C-labeled tamoxifen in spayed femal mice. Acta Pharm Toxicol 1982; 50: 161-8.
54. Greenway B, Duke D, Pym B et al. The control of human pancreatic adenocarcinoma xenografts in nude mice by hormone therapy. Br J Surg 1982; 69: 595-7.
55. Poston GJ, Townsend CM, Rajaraman S et al. Effect of somatostatin and tamoxifen on the growth of human pancreatic cancers in nude mice. Pancreas 1990; 5: 151-7.
56. Theve NO, Pousette Å, Carlström K. Adenocarcinoma of the pancreas - A hormone sensitive tumor? A preliminary report on Nolvadex treatment. Clin Oncol 1983; 9: 193-7.
57. Tönnesen K, Kamp-Jensen M. Antiestrogen therapy in pancreatic carcinoma: a preliminary report. Eur J Surg Oncol 1986; 12: 69-70.
58. Crowson MC, Dorrell A, Rolfe EB et al. A phase II study to evaluate tamoxifen in pancreatic adenocarcinoma. Eur J Surg Oncol 1986; 12: 335-6.
59. Wong A, Chan A, Arthur K. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas. Cancer Treat Rep 1987; 71: 749-50.
60. Keating JJ, Johnson PJ, Cochran AMG. A prospective randomized controlled trial of tamoxifen and cyproterone acetat in pancreatic carcinoma. Br J Cancer 1989; 60: 789-92.
61. Bakkevold KE, Pettersen A, Arnesjö B et al. Tamoxifen therapy in unresectable adenocarcinoma of the pancreas and the papilla of Vater. Br J Surg 1990; 77: 725-30.